GEN2-Recombinant COVID-19 Vaccine (CHO Cells)

GEN2-Recombinant COVID-19 Vaccine (CHO Cells) · National Vaccine and Serum Institute, China

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GEN2-Recombinant COVID-19 Vaccine (CHO Cells), covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Clinical Trial of GEN2-Recombinant COVID-19 Vaccine (CHO Cells) in Healthy People Aged 18 and Above [Phase 1]

See pricing